A biodegradable copolymer for the slow release of growth hormone expedites scarring in diabetic rats

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 81, Issue 2, 2007, Pages 291-304

  García Esteo, Francisco ^a   Pascual, Gemma ^a   Gallardo, Alberto ^b   San Román, Julio ^b   Buján, Julia ^a   Bellón, Juan Manuel ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b INSTITUTO DE CIENCIA Y TECNOLOGÍA DE POLÍMEROS   (Spain)

Author keywords

Diabetes; Drug release systems; Growth factors; Wound healing

Indexed keywords

BIODEGRADABLE POLYMERS; COPOLYMERS; DISEASE CONTROL; FIBROBLASTS; GROWTH KINETICS; HORMONES; MEDICAL PROBLEMS;

DRUG RELEASE SYSTEMS; GROWTH FACTORS; GROWTH HORMONE; WOUND HEALING;

BIOMATERIALS;

1 VINYL 2 PYRROLIDINONE; 2 HYDROXYETHYL METHACRYLATE; GROWTH HORMONE; METALLOPROTEINASE; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BIODEGRADATION; CELL GROWTH; CELL INFILTRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; FEMALE; FIBROBLAST CULTURE; HORMONE RELEASE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INCISION; MICROSCOPY; NONHUMAN; POLYMERIZATION; PROTEIN EXPRESSION; RAT; SCAR FORMATION; WOUND HEALING;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; DELAYED-ACTION PREPARATIONS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FIBROBLASTS; HUMAN GROWTH HORMONE; HUMANS; MATERIALS TESTING; POLYHYDROXYETHYL METHACRYLATE; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 34247638910     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30665     Document Type: Article

References (67)

1. Bennet NT, Schultz GS. Growth factors and wound healing: Biochemical properties of growth factors and their receptors. Am J Surg 1993;165:728-737.
2. Bennet NT, Schultz GS. Growth factors and wound healing, Part 2: Role in normal and chronic wound healing. Am J Surg 1993;166:74-81.
3. Putney SD, Burke P. Improving protein therapeutics with sustained-release formulations. Nat Biotechol 1998;16:153-157.
4. Leibowitz HM, Morello S, Stern M, Kupperman A. Effect of topically administered epidermal growth factor on corneal wound strengh. Arch Ophthalmol 1990;108:734-737.
5. Cohen P, Clemmons DR, Rosenfeld RG. Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 2000;10:297-305.
6. Nimni ME. Polypeptide growth factors: Targeted delivery systems. Biomaterials 1997;18:1201-1225.
7. Slavin J. The role of cytokines in wound healing. J Pathol 1996;178:5-10.
8. Dunaiski V, Belford DA. Contribution of circulating IGF-1 to wound repair in GH-treated rats. Growth Horm IGF Res 2002;12:381-387.
9. Gilpin DA, Barrow RE, Rutan RL, Broemeling L, Herndon DN. Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg 1994;220:19-24.
10. Atkinson JB, Kosi M, Srikanth MS, Takano K, Costin G. Growth hormone reverses impaired wound healing in protein-malnourished rats treated with corticosteroids. J Pediatr Surg 1992;27:1026-1028.
11. Takano K, Mouri N, Sakurai H, Muto S, Koshizuka K, Tada Y. Effect of growth hormone on wound healing in protein-malnourished rats treated with corticosteroids. J Pediatr Surg 1994;29:790-793.
12. Sun Y, Zhou Y, Jiang Z. The effect of growth hormone on wound healing rate in adult burns. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 1998;14:277-280.
13. Tan F, Sun Y. Clinical uses of growth hormone in burns. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 1999;15:380-382.
14. Losada F, Garcia-Luna PP, Gómez -Cia T, Garrido M, Pereira JL, Marin F, Astorga R. Effects of human recombinant growth hormone on donor-site healing in burned adults. World J Surg 2002;26:2-8.
15. Green H, Morikawa M, Nixon T. A dual effector theory of growth hormone action. Differentiation 1985;29:195-198.
16. Skalak R, Fox CF. editors. Tissue Engineering. New York: Liss; 1988.
17. Mainardes RM, Silva LP. Drug delivery systems: Past, present, and future. Curr Drug Targets 2004;5:449-455.
18. Kita M, Ogura Y, Honda Y, Hyon SH, Cha WI, Ikada Y. A polyvinyl alcohol (PVA) hydrogel as a soft contact lens material. Nippon Ganka Gakkai Zasshi 1990;94:480-483.
19. Hong Y, Chirila TV, Cuypers MJ, Constable IJ. Polymers of 1-vinyl-2-pyrrolidinone as potential vitreous substitutes: Physical selection. J Biomater Appl 1996;11:135-181.
20. Compan V, Garrido J, Manzanares JA, Andres J, Esteve JS, Lopez ML. True and apparent oxygen permeabilities of contact lenses. Optom Vis Sci 1992;69:685-690.
21. Gopferich A. Mechanisms of polymer degradation and erosion. Biomaterials 1996;17:103-114.
22. Langer R, Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature 1976;263:797-800.
23. Lou X, Garrett KL, Rakoczy PE, Chirila TV. Synthetic hydrogels as carriers in antisense therapy: Preliminary evaluation of an oligodeoxynucleotide covalent conjugate with a copolymer of 1-vinyl-2-pyrrolidinone and 2-hydroxyethyl methacrylate. J Biomater Appl 2001;15:307-320.
24. Cascone MG, Sim B, Downes S. Blends of synthetic and natural polymers as drug delivery systems for growth hormone. Biomaterials 1995;16:569-574.
25. Spanheimer RG. Correlation between decreased collagen production in diabetic animals and in cells exposed to diabetic serum: Response to insulin. Matrix 1992;12:101-107.
26. Bizot-Foulon V, Bouchard B, Hornebeck W, Dubertret L, Bertaux B. Uncoordinate expression of type I and III collagens, collagenase and tissue inhibitor of matrix metalloproteinase 1 along the in vitro proliferative lifespan of human skin fibroblasts: Regulation by all-trans retinole acid. Cell Biol Int Rep 1995;19:129-135.
27. Hehenberger K, Hansson A. High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochem Funct 1997;15:197-201.
28. Hehenberger K, Hansson A, Heilborn JD, Abdel-Halim SM, Ostensson C-G, Brismar K. Impaired proliferation and increased lactate production of dermal fibroblasts in GK-rat, a spontaneous model of non-insulin dependent diabetes mellitus. Wound Repair Regen 1999;7:65-71.
29. Loots MA, Lamme EN, Mekkes JR, Bos JD, Middelkoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res 1999;291:93-99.
30. Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC. Cellular dysfunction in the diabetes fibroblast. Impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 2003;162:303-312.
31. DeGroot LJ, Jameson JL, editors. Endocrinology. Philadelphia: W.B. Saunders; 2001.
32. Langer R, Moses M. Biocompatible controlled release polymers for delivery of polypeptides and growth factors. J Cell Biochem 1991;45:340-345.
33. Khouri RK, Koudsi B, Deune G, Hong SP, Ozbek MR, Serdar CM, Song SZ, Pierce GF. Tissue generation with growth factors. Surgery 1993;114:374-380.
34. Puolakkainen PA, Twardzik DR, Ranchalis JE, Pankey SC, Reed MJ, Gombotz WR. The enhancement in wound healing by transforming growth factor-β1 (TGF-β1) depends on the topical delivery system. J Surg Res 1995;58:321-329.
35. Benn SI, Whitsitt JS, Broadley KN, Nanney LB, Perkins D, He L, Patel M, Morgan JR, Swain WF, Davidson JM. Particle-mediated gene transfer with transforming growth factor-β1 cDNAs enhances wound repair in rat skin. J Clin Invest 1996;98:2894-2902.
36. Bitar MS. Insulin-like growth factor-I reverses diabetes-induced wound healing impairment in rats. Horm Metab Res 1997;29:383-386.
37. Massey KA, Blakeslee C, Pitkow HS. Possible therapeutic effects of growth hormone on wound healing in the diabetic patient. J Am Podiatr Med Assoc 1998;88:25-29.
38. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990;212:424-429.
39. Barret JP, Dziewulski P, Jeschke MG, Wolf SE, Herndon DN. Effects of recombinant human growth hormone on the development of burn scarring. Plast Reconstr Surg 1999;104:726-729.
40. Welsh KM, Lamit M, Morhenn VB. The effect of recombinant human growth hormone on wound healing in normal individuals. J Dermatol Surg Oncol 1991;17:942-945.
41. Lobmann R, Schultz G, Lehnert H. Molecular fundamentals of wound healing in diabetic foot syndrome. Med Klin (Munich) 2003;98:292-301.
42. Darby IA, Bisucci T, Hewitson TD, MacLellan DG. Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. Int J Biochem Cell Biol 1997;29:191-200.
43. Unterman TG, Jentel JJ, Oehler DT, Lacson RG, Hofert JF. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat. Endocrinology 1993;133:2531-2539.
44. Goya L, Rivero F, Martin MA, Alvarez C, Ramos S, de la Puente A, Pascual-Leone AM. Liver mRNA expression of IGF-I and IGFBPs in adult undernourished diabetic rats. Life Sci 1999;64:2255-2271.
45. Zaizen Y, Ford EG, Kosi M, Costin G, Atkinson JB. Growth hormone effects on wound healing in malnourished animals: A histological study. Eur J Pediatr Surg 1995;5:226-230.
46. Bazan JF. Haemopoietic receptors and helical cytokines. Immunol Today 1990;11:350-354.
47. Rasmussen LH, Garbarsch C, Schuppan D, Moe D, Horslev-Pedersen K, Gottrup F, Steenfos H. Dose response profiles of human growth hormone in subcutaneous wound chambers in rats. Eur J Surg 1995;161:157-162.
48. Regan MC, Barbul A. Regulation of wound healing by the T cell-dependent immune system. In: Yanssen H, Rooman R, Robertson JIS, editors. Wound healing. Petersfield: Wrightson Biomedical; 1991. p 21-31.
49. Galeano M, Torre V, Deodato B, Campo GM, Colonna M, Sturiale A, Squadrito F, Cavallari V, Cuccinotta D, Buemi M, Altavilla D. Raxofelast, a hydrophilic vitamin E-like antioxidant, stimulates wound healing in genetically diabetic mice. Surgery 2001;129:467-477.
50. Boyce DE, Ciampolini J, Ruge F, Murison MSC, Harding KG. Inflammatory cell subpopulations in keloid scars. Br J Plast Surg 2001;54:511-516.
51. Wojciak B, Crossan JF. The effects of T cells and their products on in vitro healing of epitenon cell microwounds. Immunology 1994;83:93-98.
52. Gouttefangeas C, Eberle M, Ruck P, Stark M, Muller JE, Becker HD, Rammensee HG, Pinocy J. Functional T lymphocytes infiltrate implanted polyvinyl alcohol foams during surgical wound closure therapy. Clin Exp Immunol 2001;124:398-405.
53. Davis PA, Corless DJ, Aspinall R, Wastell C. Effect of CD4(+) and CD8(+) cell depletion on wound healing. Br J Surg 2001;88:298-304.
54. Boyce DE, Jones WD, Ruge F, Harding KG, Moore K. The role of lymphocytes in human dermal wound healing. Br J Dermatol 2000;143:59-65.
55. Barbul A, Breslin RJ, Woodyard JP, Wasserkrug HL, Efron G. The effect of in vivo T helper and T suppressor lymphocyte depletion on wound healing. Ann Surg 1989;209:479-483.
56. Weigent DA, Baxter JB, Wear WE, Smith LR, Smith LR, Bost KL, Blalock JE. Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J 1988;2:2812-2818.
57. Hattori N, Shimatsu A, Sugita M, Kumagai S, Imura H. Immunoreactive growth hormone (GH) secretion by human lymphocytes: Augmented release by exogenous GH. Biochem Biophys Res Commun 1990;168:396-401.
58. Hooghe-Peters EL, Hooghe R, editors. Growth hormone, prolactin, and IGF-1 as lymphohemopoietic cytokines. Austin, TX: RG Landes Company; 1995.
59. Law V, Payne LC, Weigent DA. Effects of streptozotocin-induced diabetes on lymphocyte POMC and growth hormone gene expression in the rat. J Neuroimmunol 1994;49:35-44.
60. Ross R, Orland G. Human wound repair: Inflammatory cells, epithelial-mesenchymal interrelations and fibrogenesis. J Cell Biol 1968;39:152-164.
61. Nwomeh BC, Liang HX, Cohen IK, Yager DR. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 1999;81:189-195.
62. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002;45:1011-1016.
63. Wall SJ, Sampson MJ, Levell N, Murphy G. Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts. Br J Dermatol 2003;149:13-16.
64. Chandler S, Cossins J, Lury J, Wells G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-α fusion protein. Biochem Biophys Res Commun 1996;228:421-429.
65. Gronski TJ Jr, Martin RL, Kobayashi DK, Walsh BC, Holman MC, Huber M, Van Wart HE, Shapiro SD. Hydrolisis of a broad spectrum of extracellular matrix proteins by human macrophage metalloelastase. J Biol Chem 1997;272:12189-12194.
66. Hiller O, Lichte A, Oberpichler A, Kocourek A, Tschesche H. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. J Biol Chem 2000;275:33008-33013.
67. Kerkelä E, Böhling T, Herva R, Uria JA, Saarialho-Kere U. Human macrophage metalloelastase (MMP-12) expression is induced in chondrocytes during fetal development and malignant transformation. Bone 2001;29:487-493.